Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM2 | Q9P1W9 | 19/20 | 0.77 |
| ▸ | PIM3 | Q86V86 | 16/20 | 0.77 |
| ▸ | PIM1 | P11309 | 11/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6521568 | 1.00 | PIM2 (0.77) | PIM2PIM3PIM1 | |
| SCHEMBL6523019 | 0.94 | PIM2 (0.78) | PIM2PIM3PIM1 | |
| SCHEMBL6523001 | 0.94 | PIM2 (0.78) | PIM2PIM3PIM1 | |
| SCHEMBL6525059 | 0.92 | PIM2 (0.77) | PIM2PIM3PIM1 | |
| SCHEMBL6525041 | 0.92 | PIM2 (0.77) | PIM2PIM3PIM1 | |
| SCHEMBL12849733 | 0.91 | PIM2 (0.75) | PIM2PIM3PIM1 | |
| SCHEMBL6521569 | 0.90 | PIM2 (0.74) | PIM2PIM3PIM1 | |
| SCHEMBL6521554 | 0.90 | PIM2 (0.74) | PIM2PIM3PIM1 | |
| SCHEMBL6517822 | 0.90 | PIM2 (0.74) | PIM2PIM3PIM1 | |
| SCHEMBL6517801 | 0.90 | PIM2 (0.74) | PIM2PIM3PIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2475659-B1 | 4-SUBSTITUTED PYRIDIN-3-YL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | HOFFMANN LA ROCHE (CH) | 2015-10-28 | — | — | EP | claimed |
| CN-102625807-A | 4-substituted pyridin-3-yl-carboxamide compounds and methods of use | HOFFMANN LA ROCHE | 2012-08-01 | — | — | CN | claimed |
| EP-2475659-A1 | 4-SUBSTITUTED PYRIDIN-3-YL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | F. Hoffmann-La Roche AG (CH) | 2012-07-18 | — | — | EP | claimed |
| WO-2011029802-A1 | 4-SUBSTITUTED PYRIDIN-3-YL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | F. HOFFMANN-LA ROCHE AG (CH) | 2011-03-17 | — | — | WO | claimed |
| US-20110059961-A1 | 4-SUBSTITUTED PYRIDIN-3-YL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | GENENTECH, INC. | 2011-03-10 | — | — | US | claimed |
| EP-2475659-B1 | 4-SUBSTITUTED PYRIDIN-3-YL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | HOFFMANN LA ROCHE (CH) | 2015-10-28 | — | — | EP | disclosed |
| US-8435976-B2 | 4-substituted pyridin-3-yl-carboxamide compounds and methods of use | F. HOFFMANN-LA ROCHE (CH) | 2013-05-07 | — | — | US | disclosed |
| CN-102625807-A | 4-substituted pyridin-3-yl-carboxamide compounds and methods of use | HOFFMANN LA ROCHE | 2012-08-01 | — | — | CN | disclosed |
| US-20110059961-A1 | 4-SUBSTITUTED PYRIDIN-3-YL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | GENENTECH, INC. | 2011-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110059961-A1 | 4-SUBSTITUTED PYRIDIN-3-YL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | PIM1, PIM3, PIM2 | PIM2 3/4885PIM3 2/4885PIM1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.